Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 12.70M | £ 200.00K | £ 6.60M | £ 39.00M | £ 25.70M |
Total Assets | £ 1.24B | £ 1.14B | £ 1.06B | £ 1.04B | £ 1.01B |
Total Debt | £ 75.40M | £ 106.20M | £ 93.60M | £ 131.40M | £ 146.70M |
Net Debt | £ 62.70M | £ 106.00M | £ 87.00M | £ 92.40M | £ 121.00M |
Total Liabilities | £ 446.50M | £ 374.20M | £ 342.60M | £ 355.80M | £ 376.00M |
Stockholders Equity | £ 792.50M | £ 768.90M | £ 717.60M | £ 686.10M | £ 638.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |